- Navigation
- Register My DNA Kit
- Features
- Pricing
- FAQ
- About
- Labs
- Login
- Get started
Interaction | References |
---|---|
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides co-treated with irinotecan] results in increased expression of and results in increased secretion of IL1B protein] | R |
Interaction | References |
---|---|
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides co-treated with irinotecan] results in increased expression of and results in increased secretion of IL18 protein] | R |
Interaction | References |
---|---|
[Ketoconazole results in decreased activity of UGT1A1 protein] which results in decreased metabolism of irinotecan | R |
Interaction | References |
---|---|
ABCG2 affects the susceptibility to irinotecan | R |
Interaction | References |
---|---|
bisindolylmaleimide I inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | R |
Interaction | References |
---|---|
[irinotecan co-treated with Bortezomib] results in increased ubiquitination of TP53 protein | R |
Interaction | References |
---|---|
irinotecan results in increased expression of TNF mRNA | R |
Interaction | References |
---|---|
Ciprofloxacin inhibits the reaction [irinotecan promotes the reaction [Mitogens results in increased expression of IFNG protein]] | R |
Interaction | References |
---|---|
IL6 protein results in decreased susceptibility to irinotecan | R |
Interaction | References |
---|---|
gefitinib inhibits the reaction [irinotecan metabolite results in increased secretion of TGFA protein] | R |